TrialReader


Impact of Neuropsychological Evaluation on Epilepsy Treatment

NCT03202082 — Phase 2, Unknown, 100 participants, University of South Florida

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03202082
StatusUnknown
PhasePhase 2
Study typeInterventional; randomized, parallel, masking: double, health services research
Enrollment100 (Estimated)
SponsorUniversity of South Florida (Other)
ConditionsEpilepsy
InterventionsNeuropsychological testing (Behavioral)
Datesstart 2015-07-01, primary completion 2018-06-30 (estimated), completion 2018-06-30 (estimated), first posted 2017-06-28, last updated 2017-06-28
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Epilepsy All trials of Neuropsychological testing

-Summary

The present study aims to expand the evidence base of neuropsychological services in the context of medical management of epilepsy, examining whether treatment outcome and patient satisfaction with medical care are significantly improved when neuropsychological evaluation is included as an additional component of medical care within a comprehensive epilepsy center. All participants will complete an initial survey and a follow-up survey regarding views towards their epilepsy treatment. Participants will be randomized into one of two groups. One group will be given a neuropsychological battery in addition to the survey. The primary study hypothesis is that the addition of neuropsychological services to treatment-as-usual will result in significant improvements in (a) satisfaction with medical care, (b) patient perceived treatment outcome, and (c) physician-rated medical compliance. The secondary hypothesis is that participants who undergo neuropsychological evaluation will be generally satisfied with their experience with neuropsychological services.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Neuropsychological testingExperimentalBehavioral: Neuropsychological testingParticipants from this group will be administered a neuropsychological battery in addition to the initial and follow-up surveys
Treatment as usualNo interventionParticipants from this group will be administered the initial and follow-up survey.
  • Neuropsychological testing (Behavioral): Neuropsychological testing evaluates various aspects of a participants cognitive ability as well as mood.

+Outcome measures

Primary outcomes

  • Epilepsy Outcome Study Survey [2-4 months]: A brief questionnaire regarding the participants views on their epilepsy treatment

+Eligibility

Sex: All, ages: 18 Years to 89 Years

Inclusion Criteria:

* 18 years of age or older
* experiencing some degree of epilepsy-related symptoms, but not of such severity as to preclude them from being able to provide consent or undergo neuropsychological assessment (requiring extended inpatient treatment, severely aphasic, or MMSE score < 25)

Exclusion Criteria:

* Previously undergone neuropsychological testing
* Currently pursuing surgical treatment for epilepsy

+Locations (1)

FacilityCityCountryStatus
University of South FloridaTampa, FloridaUnited StatesRecruiting

My Notes